Pharmaceutical-Grade CBD: Elevating the Industry to the Next Level
June 1st 2023The cannabidiol (CBD) market reached a saturation level in recent years with products popping up around every corner—from the local gas station to the neighborhood market and more. How can consumers know which of those products are safe and reliably labeled? It is an unfortunate fact that there are bad products on the market, some that have no CBD at all despite label claims. Despite these bad actors, many companies are striving to do better and even set higher standards for the industry. For instance, Vantage Hemp Co. has made it their mission to go beyond current state requirements and produce pharmaceutical-grade CBD. Here, Deepank Utkhede, Chief Operating Officer at Vantage Hemp Co., discusses his role with the company and their goals to elevate this market to create a safe place for consumers and manufacturers.
New Research Shows that Cannabis Trichomes Trigger Positive Results on Rapid Yeast and Mold Plates
September 30th 2022Kevin McKernan, Chief Scientific Officer and Founder of Medicinal Genomics, shares some insight behind his recently published paper related to cannabis trichomes and positive results on rapid yeast and mold plates.
Chronic Pain Research Endeavors: How an App and University Are Presenting Real-World Patient Data
September 23rd 2022One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.
Americans for Safe Access Local Chapters: Meet the Dallas, Texas ASA Chapter
June 24th 2022Americans for Safe Access (ASA) is a non-profit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research. ASA was founded in 2002 by medical cannabis patient, Steph Sherer, as a vehicle for patients to advocate for the acceptance of cannabis as medicine. ASA has local chapters throughout the United States, and in this series of interviews, we introduce you to those chapters and highlight some of the state-level work being done to advocate for patients’ access and rights. In this installment, Nico Murillo, the chair of the Dallas, Texas chapter, shares some advocacy highlights from the lone star state.
Cannabis and Psychedelics Research: A Cannabis Science Conference West Preview with Dr. Denise Vidot
March 31st 2022Dr. Denise C. Vidot, an epidemiologist at the University of Miami and Founder of the International Cannabis & Psychedelic Research Collaborative, shares her research background, a small preview of her talk, “Co-Use of Cannabis and Psilocybin to Manage Mental Health Amid the COVID-19 Pandemic: Preliminary Results from the International COVID-19 Cannabis Health Study,” and more.
CannMed 2022: Medical Practicum Organizers Share Their Insight, Part I: Dr. Bonni Goldstein
January 31st 2022The upcoming CannMed conference—taking place May 3–5 in Pasadena, California—will feature an exciting full-day medical practicum organized by Bonni Goldstein, MD, (the practicum’s originator); Dustin Sulak, DO; Kevin Spelman, PhD, MCPP; and Eloise Theisen, NP, AGPCNP-BC. During this practicum, each of the presenters will share the latest research, their clinical experience, and practice guidelines related to cannabinoid therapeutics.
Compliance Matters: An Insider’s Perspective on How to Stay Up to Date on Cannabis Regulations
January 31st 2022Regulations and compliance are sometimes deemed a necessary evil, but consumer and employee safety are at the heart of those rules. The cannabis industry faces unique challenges when it comes to compliance because each state has their own rules. Federal regulation would certainly simplify matters, but until then Kim Stuck, CEO and founder of Allay Consulting, offers some practical advice for how to stay ahead of potential issues. Here, Stuck shares her background in regulatory work, the cannabis industry, her new blog coming out in Cannabis Science and Technology next month, and more.
What Can We Do for Our Veterans?
December 23rd 2021Welcome to our final 2021 edition of Cannabis Patient Care. We are closing out this year with our annual issue focused on veterans. Veterans play a special role in our society—sacrificing their safety, time, and often mental health to keep our country safe. We owe them more than a debt of gratitude and I think that point was made extremely well by Cherissa Jackson in the "Advocate Focus" piece on page 24. She suggested that we all say more than thank you to our veterans and instead ask what we can do for them. How can we help? The veterans in my life are very tough people who are reluctant to ask for help, but moving forward I will try to keep Jackson’s thought in mind and go beyond a thank you with as many veterans as I can—starting with this very issue of Cannabis Patient Care!